- Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus
- Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
- Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects
- Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
- Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4) a randomised, double-blind, placebo-controlled phase 3 trial
- Devinsky Cannabidol pharmacology and therapeutic role in epilepsy and other neuropsychiatric disorders Epilepsia 2014
- Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients
- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
- Cannabidivarin is anticonvulsant in mouse and rat
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism
- Cannabinoids for pediatric epilepsy- Up in smoke or real science-
- Cannabinoids in the Treatment of Epilepsy
- Cannabis, Cannabinoids and Tinnitus
- CANNABIS IN THE MANAGEMENT AND TREATMENT OF SEIZURES AND EPILEPSY- A SCIENTIFIC REVIEW
- CBD-enriched medical cannabis for intractable pediatric epilepsy
- Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
- Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy
- Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity
- Marijuana Use in Epilepsy- The Myth and the Reality
- On the application of cannabis in paediatrics and epileptology
- Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- The case for assessing cannabidiol in epilepsy Epilepsia 2014
- The case for medical marijuana in epilepsy Epilepsia 2014
- The current status of artisanal cannabis for the treatment of epilepsy in the United States
- The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy
- The Pharmacological Basis of Cannabis Therapy for Epilepsy
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- Understanding Cannabinoids and Epilepsy
- Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.